|
2023
|
Invention
|
Medical use of tafoxiparin.
The present invention is directed to tafoxiparin for use in the spon... |
|
|
Invention
|
New medical use of tafoxiparin. The present invention is directed to tafoxiparin for use in the s... |
|
2021
|
Invention
|
Tafoxiparin for the treatment of preeclampsia.
The present invention is directed to the use of t... |
|
|
Invention
|
Tafoxiparin for the treatment of preeclampsia. The present invention is directed to the use of th... |
|
2014
|
Invention
|
Processes for the production of chemically-modified heparins. The present invention relates to a ... |
|
|
Invention
|
New processes for the production of chemically-modified heparins. The present invention relates t... |
|
2013
|
Invention
|
Polysaccharide compositions and methods of use for the treatment and prevention of disorders asso... |
|
|
Invention
|
Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a ut... |
|
|
Invention
|
Method for treatment of labor arrest.
The present invention refers to the use of certain sulfate... |
|
|
Invention
|
Combination treatment comprising sulphated glycosaminoglycans for inducing labor.
The present in... |
|
|
Invention
|
Combination treatment comprising sulphated glycosaminoglycans for inducing labor. The present inv... |
|
|
Invention
|
Method for treatment of labor arrest. The present invention refers to the use of certain sulfated... |
|
2012
|
Invention
|
Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical ... |
|
|
Invention
|
Treatment of cytokine mediated conditions. The present invention relates to the usefulness of a s... |
|
|
Invention
|
Use of sulfated glycosaminoglycans for establishing effective labor in women. A method of treatin... |
|
2008
|
Invention
|
Non-anticoagulant polysaccharide compositions. Polysaccharide preparations lacking substantial an... |
|
|
Invention
|
Use of sulfated glycosaminoglycans for establishing effective labor in women. The invention refer... |
